ConductScience.org, home

Paper340950

Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

Wintroub BU and 4 others. N Engl J Med, 1978. Cited by 157 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. Papers, record 340950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/340950

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.
PubMed
Journal
N Engl J Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
157
iCite
Relative citation ratio, by iCite
4.08
iCite
Revised in PubMed
2022-03-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wintroub BUB U
2Mihm MC JrM C
3Goetzl EJE J
4Soter NAN A
5Austen KFK F

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mast CellsMajor topic
SkinMajor topic
Skin Diseases, VesiculobullousMajor topic
Autoantibodies
Basement Membrane
Chemotaxis, Leukocyte
Complement C3
Humans

Source PubMed

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.

PMIDTitleJournalYearIn PapersSource
41,729,378Autoimmune Bullous Diseases: Therapeutic Update.Drugs2026https://conductscience.org/library/papers/41729378PubMed
41,567,205The role of immunoglobulin E in non-atopic disorders.Front Immunol2025https://conductscience.org/library/papers/41567205PubMed
39,932,658Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.Clin Rev Allergy Immunol2025https://conductscience.org/library/papers/39932658PubMed
39,425,892Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review).Adv Ther2024https://conductscience.org/library/papers/39425892PubMed
36,477,831Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom.J Dermatol2023https://conductscience.org/library/papers/36477831PubMed
36,430,483Mast Cells and Interleukins.Int J Mol Sci2022https://conductscience.org/library/papers/36430483PubMed
36,134,505Elevated levels of sCD48 are inversely correlated with markers of disease activity in bullous pemphigoid.Exp Dermatol2023https://conductscience.org/library/papers/36134505PubMed
35,817,512Sex Differences in Mast Cell-Associated Disorders: A Life Span Perspective.Cold Spring Harb Perspect Biol2022https://conductscience.org/library/papers/35817512PubMed
35,665,207Mast cell-deficient mice Mcpt5Cre/Dicer fl/fl redefine the role of mast cells in experimental bullous pemphigoid.Skin Health Dis2022https://conductscience.org/library/papers/35665207PubMed
34,200,214May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature.Microorganisms2021https://conductscience.org/library/papers/34200214PubMed
31,297,118Proteases in Pemphigoid Diseases.Front Immunol2019https://conductscience.org/library/papers/31297118PubMed
29,731,653Histologic characterization of cellular infiltration in autoimmune subepidermal bullous diseases in a tertiary hospital in Saudi Arabia.Clin Cosmet Investig Dermatol2018https://conductscience.org/library/papers/29731653PubMed
29,545,809The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.Front Immunol2018https://conductscience.org/library/papers/29545809PubMed
29,541,076The Role of Mast Cells in Autoimmune Bullous Dermatoses.Front Immunol2018https://conductscience.org/library/papers/29541076PubMed
28,496,445Eosinophils in Autoimmune Diseases.Front Immunol2017https://conductscience.org/library/papers/28496445PubMed
25,944,979Mast cell and autoimmune diseases.Mediators Inflamm2015https://conductscience.org/library/papers/25944979PubMed
25,400,334Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.Mediators Inflamm2014https://conductscience.org/library/papers/25400334PubMed
25,062,998Mast cell function: a new vision of an old cell.J Histochem Cytochem2014https://conductscience.org/library/papers/25062998PubMed
24,954,907Omalizumab therapy for bullous pemphigoid.J Am Acad Dermatol2014https://conductscience.org/library/papers/24954907PubMed
24,845,463Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.Immunol Res2014https://conductscience.org/library/papers/24845463PubMed

See all 44 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/340950

GET https://conductscience.org/api/papers/v1/340950/cited_by?page=2